{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:56:11Z","timestamp":1780451771697,"version":"3.54.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.gtc.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T08:46:04Z","timestamp":1554108364000},"page":"291-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["IgG4-Related Disease with Emphasis on Its Gastrointestinal Manifestation"],"prefix":"10.1016","volume":"48","author":[{"given":"Bijal","family":"Vashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Khosroshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0046-8177(91)90087-6","article-title":"Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas","volume":"22","author":"Kawaguchi","year":"1991","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.gtc.2019.02.008_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/BF02285209","article-title":"Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis","volume":"40","author":"Yoshida","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.gtc.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00535-006-1862-6","article-title":"Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease","volume":"41","author":"Kamisawa","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9976","key":"10.1016\/j.gtc.2019.02.008_bib6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/BOR.0000000000000133","article-title":"An update on IgG4-related disease","volume":"27","author":"Wallace","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.gtc.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gtc.2019.02.008_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Brito-Zeron","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas"},{"issue":"15","key":"10.1016\/j.gtc.2019.02.008_bib11","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.gtc.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.gtc.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.gtc.2019.02.008_bib16","doi-asserted-by":"crossref","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib18","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.26999","article-title":"Exposure to occupational antigens might predispose to IgG4-related disease","volume":"60","author":"de Buy Wenniger","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gtc.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nri1714","article-title":"Follicular B helper T\u00a0cells in antibody responses and autoimmunity","volume":"5","author":"Vinuesa","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T\u00a0cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gtc.2019.02.008_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T\u00a0cells and the involvement of follicular helper 1 T\u00a0cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2018.06.082","article-title":"Gastrointestinal and extra-intestinal manifestations of immunoglobulin G4-related disease","volume":"155","author":"Miyabe","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gtc.2019.02.008_bib26","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.gtc.2019.02.008_bib27","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.gtc.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","article-title":"Diagnosis of autoimmune pancreatitis: the mayo clinic experience","volume":"4","author":"Chari","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41395-018-0146-0","article-title":"Autoimmune pancreatitis","volume":"113","author":"Nagpal","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PAS.0b013e3182027717","article-title":"Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance","volume":"35","author":"Deshpande","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00428-004-1140-z","article-title":"Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens","volume":"445","author":"Zamboni","year":"2004","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.gtc.2019.02.008_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"issue":"7","key":"10.1016\/j.gtc.2019.02.008_bib33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00535-016-1286-x","article-title":"The 2016 diagnostic criteria for primary sclerosing cholangitis","volume":"52","author":"Nakazawa","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13244-018-0618-1","article-title":"Abdominal manifestations of IgG4-related disease: a pictorial review","volume":"9","author":"Tang","year":"2018","journal-title":"Insights Imaging"},{"issue":"5","key":"10.1016\/j.gtc.2019.02.008_bib35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1148\/rg.315105735","article-title":"IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations","volume":"31","author":"Vlachou","year":"2011","journal-title":"Radiographics"},{"issue":"9","key":"10.1016\/j.gtc.2019.02.008_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2011.05.019","article-title":"Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma","volume":"9","author":"Kalaitzakis","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5107(04)02229-1","article-title":"Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis","volume":"60","author":"Nakazawa","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00535-012-0652-6","article-title":"The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis","volume":"48","author":"Itoi","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00534-010-0320-2","article-title":"Diagnostic procedures for IgG4-related sclerosing cholangitis","volume":"18","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00535-002-1108-1","article-title":"Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid","volume":"38","author":"Kojima","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib41","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.mcg.0000180629.77066.6c","article-title":"Extrapancreatic lesions in autoimmune pancreatitis","volume":"39","author":"Kamisawa","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2019.02.008_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","article-title":"Autoimmune pancreatitis and IgG4-related sclerosing disease","volume":"7","author":"Kamisawa","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib43","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2007.122283","article-title":"IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis","volume":"56","author":"Umemura","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2019.02.008_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0036-1584320","article-title":"Histopathology of IgG4-related autoimmune hepatitis and IgG4-related hepatopathy in IgG4-related disease","volume":"36","author":"Nakanuma","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-010-0319-0","article-title":"Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation","volume":"46","author":"Naitoh","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1542-3565(03)00221-0","article-title":"Involvement of the biliary system in autoimmune pancreatitis: a follow-up study","volume":"1","author":"Hirano","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2019.02.008_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.path.2013.05.004","article-title":"IgG4-related disorders of the gastrointestinal tract","volume":"6","author":"Lew","year":"2013","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5946\/ce.2015.074","article-title":"Immunoglobulin G4-related inflammatory pseudotumor presenting as a solitary mass in the stomach","volume":"49","author":"Cheong","year":"2016","journal-title":"Clin Endosc"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib49","first-page":"610","article-title":"Gastric involvement in autoimmune pancreatitis: MDCT and histopathologic features","volume":"11","author":"Baez","year":"2010","journal-title":"JOP"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/pin.12364","article-title":"IgG4-related disease manifesting the gastric wall thickening","volume":"66","author":"Kawano","year":"2016","journal-title":"Pathol Int"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12328-015-0617-4","article-title":"A\u00a0case of IgG4-related mesenteritis","volume":"8","author":"Mori","year":"2015","journal-title":"Clin J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/jcp.2008.057869","article-title":"Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders?","volume":"61","author":"Chen","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1440-1827.2012.02805.x","article-title":"IgG4-related sclerosing mesenteritis: a rare mesenteric disease of unknown etiology","volume":"62","author":"Minato","year":"2012","journal-title":"Pathol Int"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib54","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000478-199704000-00004","article-title":"Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity?","volume":"21","author":"Emory","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gtc.2019.02.008_bib55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cgh.2007.02.032","article-title":"Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2011.07.004","article-title":"IgG4-related systemic disease as a cause of \"idiopathic\" orbital inflammation, including orbital myositis, and trigeminal nerve involvement","volume":"57","author":"Wallace","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/14397595.2013.852842","article-title":"IgG4-related disease involving the sclera","volume":"24","author":"Ohno","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.anl.2011.01.023","article-title":"A\u00a0novel concept of Mikulicz's disease as IgG4-related disease","volume":"39","author":"Himi","year":"2012","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2004.10.005","article-title":"Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy)","volume":"4","author":"Yamamoto","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.gtc.2019.02.008_bib61","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00296-009-0925-4","article-title":"Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome","volume":"30","author":"Saeki","year":"2009","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib63","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.2013.191","article-title":"The clinical course of patients with IgG4-related kidney disease","volume":"84","author":"Saeki","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib64","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.rdc.2007.07.013","article-title":"Retroperitoneal fibrosis: evolving concepts","volume":"33","author":"Vaglio","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib66","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ki.5002427","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis","volume":"72","author":"Corradi","year":"2007","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib67","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","article-title":"Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation","volume":"88","author":"Scheel","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.gtc.2019.02.008_bib68","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","article-title":"IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2511080965","article-title":"Immunoglobulin G4-related lung disease: CT findings with pathologic correlations","volume":"251","author":"Inoue","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gtc.2019.02.008_bib71","doi-asserted-by":"crossref","first-page":"32035","DOI":"10.1038\/srep32035","article-title":"Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gtc.2019.02.008_bib72","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2019.02.008_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.gtc.2019.02.008_bib74","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib75","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gtc.2019.02.008_bib76","first-page":"61","article-title":"The immunobiology of immunoglobulin G4 and complement activation pathways in IgG4-related disease","volume":"401","author":"Kawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.28568","article-title":"Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies","volume":"64","author":"Doorenspleet","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib78","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib79","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.anai.2015.04.011","article-title":"IgG4-related disease: a primer on diagnosis and management","volume":"114","author":"Ghably","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.gtc.2019.02.008_bib80","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/his.13136","article-title":"IgG4-related disease \u2013 experience of 100 consecutive cases from a specialist centre","volume":"70","author":"Bateman","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.gtc.2019.02.008_bib81","doi-asserted-by":"crossref","first-page":"580814","DOI":"10.1155\/2012\/580814","article-title":"Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease","volume":"2012","author":"Masaki","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"7","key":"10.1016\/j.gtc.2019.02.008_bib82","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"26","key":"10.1016\/j.gtc.2019.02.008_bib83","doi-asserted-by":"crossref","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","article-title":"Therapeutic approach to IgG4-related disease: a systematic review","volume":"95","author":"Brito-Zeron","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.gtc.2019.02.008_bib84","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.gtc.2019.02.008_bib85","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib86","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.gtc.2019.02.008_bib87","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1136\/annrheumdis-2015-207625","article-title":"Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years","volume":"74","author":"Yamamoto","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.gtc.2019.02.008_bib88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLML.2010.n.034","article-title":"Treatment with bortezomib of a patient having hyper IgG4 disease","volume":"10","author":"Khan","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.gtc.2019.02.008_bib89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/09273948.2012.714045","article-title":"Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment","volume":"20","author":"Balaskas","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.gtc.2019.02.008_bib90","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/annrheumdis-2016-209368","article-title":"Efficacy of abatacept for IgG4-related disease over 8\u00a0months","volume":"75","author":"Yamamoto","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.gie.2008.11.029","article-title":"Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video)","volume":"70","author":"Mahajan","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.gtc.2019.02.008_bib92","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2169\/naika.101.1079","article-title":"Case report; acute renal failure due to IgG4-related retroperitoneal fibrosis","volume":"101","author":"Maeta","year":"2012","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.gtc.2019.02.008_bib93","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.18632\/oncotarget.23103","article-title":"Clinical features and prognostic factors of ten patients with renal failure caused by IgG4-related retroperitoneal fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855319300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855319300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:28:15Z","timestamp":1760178495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855319300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0889855319300093"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2019.02.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-Related Disease with Emphasis on Its Gastrointestinal Manifestation","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}